Science Inventory

Chapter Eight: Neurotoxicity of poly- and perfluoroalkyl substances (PFAS): Epidemiological and rodent studies of behavioral outcomes

Citation:

O'Shaughnessy, Katherine, W. Oshiro, T. Jackson, H. Starnes, A. Sasser, AND B. McMichael. Chapter Eight: Neurotoxicity of poly- and perfluoroalkyl substances (PFAS): Epidemiological and rodent studies of behavioral outcomes. Edition 1, Chapter 8, Prasada Rao Kodavanti, Lucio G. Costa, MIchael Aschner (ed.), Neurotoxicity of Halogenated Organic Compounds. ELSEVIER, AMSTERDAM, Holland, 10:325-366, (2023). https://doi.org/10.1016/bs.ant.2023.09.002

Impact/Purpose:

Poly- and perfluoroalkyl substances (PFAS) are a large class of compounds used in a variety of industrial applications. Despite their widespread use in bulk quantities, significant concerns have been raised regarding their biological and environmental persistence. In addition, studies have shown some PFAS are reproductive, endocrine, and hepatic toxicants in laboratory animals. Although less is known about the potential effects on the nervous system, PFAS are detectable in human cerebrospinal fluid and brain tissue, suggesting they cross the blood-brain and blood-cerebrospinal fluid barriers. Thus, neurotoxicity during development and adulthood is of concern. Here we summarize human and rodent data regarding the neurotoxicity of PFAS. Specifically, we discuss potential neurological dysfunction related to motor activity, attention/anxiety, and learning and memory are reviewed. Overall, the data are mixed; findings vary depending on the PFAS studied, when the exposure was administered or measured, and the endpoint assessed. However, given the long half-lives of many PFAS and the ubiquity of human exposure, more studies are needed to fully understand how these compounds could interfere with neurobehavior in humans and animal models. 

Description:

Poly- and perfluoroalkyl substances (PFAS) are a large class of halogenated organic compounds (HOCs, also called organohalogens) utilized in a variety of industrial applications. Despite their widespread use in bulk quantities, significant concerns have been raised regarding their biological and environmental persistence. In addition, studies have shown some PFAS are reproductive, endocrine, and hepatic toxicants in laboratory animals. Although less is known about potential effects on the nervous system, PFAS are detectable in human cerebrospinal fluid and brain tissue, suggesting they cross the blood–brain and blood–cerebrospinal fluid barriers. Thus, neurotoxicity during development and adulthood is of concern. Here we summarize epidemiological and rodent data regarding the neurotoxicity of PFAS. Specifically, complex indicators of neurological dysfunction related to motor activity, attention/anxiety, and learning and memory are reviewed. Overall, data are mixed; findings vary depending on the congener studied, when the exposure was administered or measured, and the endpoint(s) assessed. However, given the long half-lives of many PFAS and the ubiquity of human exposure, more studies are needed to fully understand how these compounds could interfere with neurobehavior in humans and animal models.

Record Details:

Record Type:DOCUMENT( BOOK CHAPTER)
Product Published Date:10/27/2023
Record Last Revised:06/07/2024
OMB Category:Other
Record ID: 361687